Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma
about
Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas: A Retrospective Cohort StudyA clinician's guide to double hit lymphomas.P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma.TP53 and OSBPL10 alterations in diffuse large B-cell lymphoma: prognostic markers identified via exome analysis of cases with extreme prognosis.Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP
P2860
Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma
description
article
@en
im November 2014 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2014
@uk
name
Combining MYC, BCL2 and TP53 g ...... diffuse large B-cell lymphoma
@en
Combining MYC, BCL2 and TP53 g ...... diffuse large B-cell lymphoma
@nl
type
label
Combining MYC, BCL2 and TP53 g ...... diffuse large B-cell lymphoma
@en
Combining MYC, BCL2 and TP53 g ...... diffuse large B-cell lymphoma
@nl
prefLabel
Combining MYC, BCL2 and TP53 g ...... diffuse large B-cell lymphoma
@en
Combining MYC, BCL2 and TP53 g ...... diffuse large B-cell lymphoma
@nl
P2093
P2860
P50
P1433
P1476
Combining MYC, BCL2 and TP53 g ...... diffuse large B-cell lymphoma
@en
P2093
Harald Holte
Idun Fiskvik
Klaus Beiske
Marja-Liisa Karjalainen-Lindsberg
P2860
P304
P356
10.3109/10428194.2014.970550
P577
2014-11-19T00:00:00Z